These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3049837)
1. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models. Givner LB; Edwards MS; Baker CJ J Infect Dis; 1988 Oct; 158(4):724-30. PubMed ID: 3049837 [TBL] [Abstract][Full Text] [Related]
2. Pooled human IgG hyperimmune for type III group B streptococci: evaluation against multiple strains in vitro and in experimental disease. Givner LB; Baker CJ J Infect Dis; 1991 May; 163(5):1141-5. PubMed ID: 2019763 [TBL] [Abstract][Full Text] [Related]
3. Immune globulin for intravenous use: enhancement of in vitro opsonophagocytic activity of neonatal serum. Givner LB; Edwards MS; Anderson DC; Baker CJ J Infect Dis; 1985 Feb; 151(2):217-20. PubMed ID: 3918123 [TBL] [Abstract][Full Text] [Related]
4. Potential use of intravenous immune globulin for group B streptococcal infection. Baker CJ; Noya FJ Rev Infect Dis; 1990; 12 Suppl 4():S476-82. PubMed ID: 2194272 [TBL] [Abstract][Full Text] [Related]
5. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci. Fujieda M; Aoyagi Y; Matsubara K; Takeuchi Y; Fujimaki W; Matsushita M; Bohnsack JF; Takahashi S Infect Immun; 2012 Jun; 80(6):2053-60. PubMed ID: 22451515 [TBL] [Abstract][Full Text] [Related]
6. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models. Givner LB Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536 [TBL] [Abstract][Full Text] [Related]
7. Functional activities of various preparations of human intravenous immunoglobulin against type III group B Streptococcus. Kim KS; Wass CA; Kang JH; Anthony BF J Infect Dis; 1986 Jun; 153(6):1092-7. PubMed ID: 3517187 [TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview. Fischer GW Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355 [TBL] [Abstract][Full Text] [Related]
9. The opsonic antibody response of female rats to type III group B streptococcal immunization: a model for maternal immunity. Heiman HS; Weisman LE Vet Immunol Immunopathol; 1990 Jan; 24(1):79-89. PubMed ID: 2180204 [TBL] [Abstract][Full Text] [Related]
10. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648 [TBL] [Abstract][Full Text] [Related]
11. Type III group B Streptococcus: functional interaction with IgG subclass antibodies. Givner LB; Baker CJ; Edwards MS J Infect Dis; 1987 Mar; 155(3):532-9. PubMed ID: 3543156 [TBL] [Abstract][Full Text] [Related]
12. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody. Kim KS; Wass CA; Hong JK; Concepcion NF; Anthony BF Pediatr Res; 1988 Nov; 24(5):628-32. PubMed ID: 3060825 [TBL] [Abstract][Full Text] [Related]
13. Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci. Hill HR; Gonzales LA; Knappe WA; Fischer GW; Kelsey DK; Raff HV J Infect Dis; 1991 Apr; 163(4):792-8. PubMed ID: 2010632 [TBL] [Abstract][Full Text] [Related]
14. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates. Weisman LE; Anthony BF; Hemming VG; Fischer GW J Pediatr; 1993 Jun; 122(6):929-37. PubMed ID: 8501574 [TBL] [Abstract][Full Text] [Related]
15. Polyvalent group B streptococcal immune globulin for intravenous administration: overview. Fischer GW; Hemming VG; Gloser HP; Bachmayer H; von Pilar CE; Wilson SR; Baron PA Rev Infect Dis; 1990; 12 Suppl 4():S483-9; discussion S489-91. PubMed ID: 2194273 [TBL] [Abstract][Full Text] [Related]
16. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698 [TBL] [Abstract][Full Text] [Related]
17. Opsonic activity of human IgG and IgM antibody for type III group B streptococci. Anthony BF; Concepcion NF Pediatr Res; 1989 Oct; 26(4):383-7. PubMed ID: 2677951 [TBL] [Abstract][Full Text] [Related]
18. Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci. Fischer GW; Wilson SR; Hunter KW J Clin Immunol; 1982 Apr; 2(2 Suppl):31S-35S. PubMed ID: 7045156 [TBL] [Abstract][Full Text] [Related]
19. Development of IgM antibody to group B Streptococcus type III in human infants. Boyer KM; Klegerman ME; Gotoff SP J Infect Dis; 1992 Jun; 165(6):1049-55. PubMed ID: 1583322 [TBL] [Abstract][Full Text] [Related]
20. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk. Lagergård T; Thiringer K; Wassén L; Schneerson R; Trollfors B Eur J Pediatr; 1992 Feb; 151(2):98-102. PubMed ID: 1537371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]